Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style S ...

May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the "Notes") under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in a ...

May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the "Notes") under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in a ...

Philips (PHG) recently announced the wide availability of its ambulatory cardiac monitoring service in Spain. The service is brought together by integrating its wearable ePatch device with its AI-driven Cardiologs analytics platform, enabling healthcare professionals to detect life-threatening heart arrhythmias, improve patient comfort, and potentially improve clinical outcomes. While Philips' ePatch offers 14-day continuous monitoring for heart and blood pressure, enhancing the detection and diagnosis of A ...

May 22, 2024 Amsterdam, the Netherlands, and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch paired with its AI-driven Cardiologs analytics platform. 14 Spanish healthcare providers across the country are now using the company's ePatch extended wear Holter monitors to detect life-threatening heart arrhythmias such as atrial fibri ...

Core Insights - Royal Philips has successfully launched its ambulatory cardiac monitoring service in Spain, utilizing the ePatch wearable device and AI-driven Cardiologs analytics platform to enhance detection of heart arrhythmias like atrial fibrillation (AF) [1][2][9] Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation, generating sales of EUR 18.2 billion in 2023 and employing approximately 69,100 people globally [11] Product Features - The ePatch provides reliable data for up to 14 days of continuous monitoring, significantly improving the detection and diagnosis of AF, which is often undetected due to its subtle symptoms [2][3] - The device is user-friendly, allowing for quick application and integration with an analysis program, which facilitates rapid review of recordings and enhances patient comfort by eliminating cumbersome cables [3][6] Clinical Impact - The ePatch has been shown to expedite hospital discharge for patients, with 80 patients discharged in 2023, leading to a reduced average length of stay and an estimated cost reduction of €28,800 [3][9] - More than 1,500 patients are currently being monitored with the ePatch across various hospitals in Spain, helping to alleviate waiting lists that accumulated during the COVID-19 pandemic [5] Pilot Programs - Pilot projects are being conducted in major hospitals across Spain, including Madrid, Barcelona, and Bilbao, focusing on monitoring patients post-cardiac procedures and studying the relationship between magnesium insufficiency and AF [4][10] Comparative Effectiveness - A recent study indicated that the ePatch detected 2x more clinically significant heart arrhythmias during 7 days of monitoring and over 2.5x as many during 14 days compared to conventional 24-hour Holter monitoring [7]

Core Insights - Philips Foundation aims to provide access to quality healthcare for 100 million people annually in underserved communities by 2030, with over 28 million people reached in 2023, indicating progress towards this target [2][9] - The foundation executed 22 ongoing and new initiatives in 2023 in collaboration with various partners, showcasing its commitment to improving healthcare access [3][9] - The foundation's strategy emphasizes building local ecosystems and fostering collaboration to enhance healthcare delivery, particularly through early screening and diagnosis [6][9] Investment and Initiatives - Philips Foundation Impact Investments B.V. supported 13 social enterprises in 2023, with four investments made, including three new and one follow-on investment [7][9] - The foundation continues to prioritize areas such as mother and child health, non-communicable disease detection, and emergency care services [5][9] - The focus on social entrepreneurship aims to create lasting access to medical services while considering the socio-economic conditions of underserved populations [8][9] Leadership and Vision - The newly appointed Chair of the Board expressed pride in the foundation's contributions and emphasized the importance of sustainable development in healthcare [4] - The foundation's director highlighted the need for an interconnected ecosystem of diverse organizations to drive innovation and collaboration towards achieving its 2030 goal [8]

May 21, 2024 Amsterdam, the Netherlands – Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, today announced the publication of its 2023 Annual Report. Philips Foundation and its partners provided access to quality healthcare for over 28 million people in 2023 – an increase demonstrating the foundation's progress towards its 2030 target. The consolidated report of Philips Foundation and its social impact investment v ...

Koninklijke Philips (PHG) recently announced the retrospective study results highlighting the financial and medical advantages of Philips' AI-powered cardiac care solutions, which were presented at the Heart Rhythm Annual Meeting in Boston. Three studies demonstrate how Philips mobile cardiac outpatient telemetry (MCOT) wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs. Price Performance Notable ...

May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands and Boston, USA – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips' AI-powered cardiac care solutions at the Heart Rhythm Annual Meeti ...